How 'designer molecules' are bringing a breakthrough for patients with metastatic cancer
Researcher Hermen Overkleeft is studying sugar molecules in his laboratory to develop innovative treatments for complex conditions. These findings serve as the foundation for new medications targeting hereditary metabolic disorders and metastatic cancer.
Based on reporting by ad. Translated and condensed by LocalHeadlines.



